Lexogen is a biotech company established in 2007. Lexogen’s team of highly qualified molecular biologists, engineers and bioinformaticians has developed powerful proprietary technologies for transcriptome analyses using Next Generation Sequencing (NGS).

Lexogen’s products empower researchers to analyze the expression of individual genes as well as the complete transcriptome with unprecedented accuracy.

Lexogen GmbH
Campus-Vienna-Biocenter 5
1030 Vienna
Building: VBC5 – Map

+43 (0) 1 345 12 12